Health Level Seven International

The Sequoia Project and HL7 Enter Strategic Collaboration To Advance FHIR Implementations Nationwide

Retrieved on: 
Thursday, February 29, 2024
Education, FHIR, ANN, Public sector, HL7, Authentication, Patient, Health Level Seven International, FAST, ONC

“We are thrilled to announce this alliance with HL7,” said Mariann Yeager, CEO of The Sequoia Project.

Key Points: 
  • “We are thrilled to announce this alliance with HL7,” said Mariann Yeager, CEO of The Sequoia Project.
  • “We look forward to working with HL7, alongside private and public sector subject matter experts, to advance nationwide FHIR implementation to improve interoperability nationwide.”
    Through this strategic relationship, HL7 and The Sequoia Project aim to continue working together in areas of mutual interest, including standards deployment and adoption, alignment between HL7 FHIR Accelerator projects and Sequoia initiatives, and creating a feedback loop to HL7 based on lessons learned from real-world production-level exchange initiatives, education, and testing.
  • "At HL7, we are delighted to continue the journey toward meaningful interoperability with The Sequoia Project,” said Charles Jaffe, M.D., Ph.D., HL7 CEO.
  • “Close collaboration is certain speed to market health IT interoperability improvements to reduce the strain on health systems, diminish clinician burden, and improve the lives of our patients."

OpenClinica Strengthens Commitment to eSource and SMART on FHIR

Retrieved on: 
Wednesday, September 20, 2023
Openclinica, Society, Health Level Seven International, Consortium, Interview, AUC, Clinical trial, FHIR, RWD, CDMS, EHR, Patient safety, Fast Healthcare Interoperability Resources, ESourcing Capability Model, Managing editor, Festival, HL7, Conference, DIA, SMART, Cal Collins, Pharmaceutical industry

NEEDHAM, Mass., Sept. 20, 2023 /PRNewswire-PRWeb/ -- OpenClinica announced today the company joined the Society for Clinical Data Management (SCDM) eSource Implementation Consortium Taskforce. Additionally, CEO Cal Collins will lead an educational session at the SCDM Annual Conference, October 8-11, 2023, in San Diego. Collins, a steering committee member of Vulcan, one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators, is chairing the SCDM 2023 session, Are you ready for EHR eSource? Lessons from the field, October 11, 9:00-10:00 am Pacific. In the October 11 session, Collins and panelists will discuss experiences, strategies, and proven tactics around the successful adoption and scaling of eSource integration at clinical trial sites from multiple perspectives, with a focus on EHR-to-EDC.

Key Points: 
  • Collins, a steering committee member of Vulcan , one of Health Level Seven's (HL7) eight Fast Healthcare Interoperability (FHIR) Accelerators , is chairing the SCDM 2023 session, Are you ready for EHR eSource?
  • OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins.
  • "OpenClinica's commitment to eSource and SMART on FHIR is second to none," emphasized Cal Collins, OpenClinica CEO.
  • OpenClinica and Collins have created eSource and SMART on FHIR educational resources, including:
    An interview with Applied Clinical Trials, which can be viewed at: https://www.appliedclinicaltrialsonline.com/view/cal-collins-discusses-t... .

OpenClinica CEO Cal Collins Chosen to Present at DIA 2023

Retrieved on: 
Tuesday, June 6, 2023
Real, Society, Health Level Seven International, Collins, Cerner Enviza, Registry, Clinical trial, Electronic health record, FHIR, Dave deBronkart, RWD, Openclinica, Patient participation, EHR, Fast Healthcare Interoperability Resources, BMJ, Accelerator, HL7, DIA, SMART, Conference, Cal Collins, Pharmaceutical industry

WALTHAM, Mass., June 6, 2023 /PRNewswire-PRWeb/ -- OpenClinica proudly announces CEO Cal Collins is speaking at the DIA 2023 Global Annual Meeting in Boston, MA, June 25-29. Collins, a steering committee member of the Vulcan Program, Health Level Seven's (HL7) newest Fast Healthcare Interoperability (FHIR) Accelerator, will discuss how SMART on FHIR is the key to unlocking real-world data. His session, SMART on FHIR: Integrating Electronic Health Records as Real-World Data, also includes:

Key Points: 
  • WALTHAM, Mass., June 6, 2023 /PRNewswire-PRWeb/ -- OpenClinica proudly announces CEO Cal Collins is speaking at the DIA 2023 Global Annual Meeting in Boston, MA, June 25-29.
  • DIA 2023 is the largest global multidisciplinary event for life sciences professionals.
  • For more information about Collins' DIA 2023 Session, June 27, 4:00 – 5:00 pm, click here .
  • To schedule a time to discuss SMART on FHIR with Collins and the OpenClinica team, visit: https://www.openclinica.com/contact-us/

Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public

Retrieved on: 
Wednesday, March 29, 2023
Online, Social responsibility, Artesunate, Idiopathic pulmonary fibrosis, Rituximab, Fosun Pharma, MPP, COVID-19, Family, Spasm, Multimedia, Corporate social responsibility, Axicabtagene ciloleucel, CSR, Medicines Patent Pool, Psoriasis, The Bund Finance Center, Occupational Safety and Health Act 1994, MSCI, Health Level Seven International, Patient, Annual report, Adalimumab, Developed country, EHS, Trastuzumab, Diagnosis, ESG, R, Rare, Immunodeficiency, Health, Pulmonary hypertension, Environment, Air pollution, RMB, Safety, Malaria, Pharmaceutical industry, Azvudine, Eurofarma, Organon

As before, Fosun Pharma achieved a five-star rating, as evaluated by the China CSR Report Rating Expert Committee, for the outstanding performance reported.

Key Points: 
  • As before, Fosun Pharma achieved a five-star rating, as evaluated by the China CSR Report Rating Expert Committee, for the outstanding performance reported.
  • Through its strengths, Fosun Pharma is also helping to solve drug accessibility problems in developing countries and underdeveloped areas.
  • Moreover, Fosun Pharma owns industry-leading capability in in&out licensing and internationalization, maximizing the value of each innovative product.
  • Furthermore, Fosun Pharma is continually striving for excellence, improving its product quality and medical services, and launched Fosun Pharma Operation Excellence (FOPEX) in 2016.

Fujitsu launches new cloud-based platform for healthcare sector in Japan, promoting personalized healthcare and drug development

Retrieved on: 
Tuesday, March 28, 2023
Insurance, Allergy, Ministry of Internal Affairs and Communications, Drug development, Information system, Process safety management, MHLW, Health informatics, Internet of things, Health Level Seven International, Communication, Internal affairs, Microsoft, FHIR, Research, Doctor of Philosophy, Problem-Oriented Medical Information System, Behavior, Sapporo Medical University, Development, Healthy Living, Data analysis, MD, Patient, Collection, Health Level 7, Diagnosis, Azure, HL7, AI, Perelman Center for Advanced Medicine, Security Technical Implementation Guide, Education, Health information exchange, Disease, Pharmaceutical industry, Medical device, Medical imaging, Nursing, Health care, Life, Health, Fujitsu

Fujitsu will offer the new platform to medical institutions and pharmaceutical companies in Japan starting March 28, 2023.

Key Points: 
  • Fujitsu will offer the new platform to medical institutions and pharmaceutical companies in Japan starting March 28, 2023.
  • "Microsoft is utilizing cloud services and AI technologies in the healthcare field and promoting the next generation standards framework HL7 FHIR.
  • Health Level Seven, Inc. is an organization dedicated to developing and promoting standards for healthcare information.
  • Health Level Seven, Inc. is an organization dedicated to developing and promoting standards for healthcare information.

FCW Selects MITRE’s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree

Retrieved on: 
Monday, February 27, 2023
Data Management, Other Science, Practice Management, Technology, Research, General Health, Public Policy, Government, Other Health, Surgery, Pharmaceutical, Oncology, Health Technology, Hospitals, Clinical Trials, Cardiology, Biotechnology, Software, Health, White House, Federal Government, Science, Cancer, Joe Biden, Partnership, National Cancer Institute, Health information management, HL7, Patient, Health Level Seven International, Doctor of Philosophy, Schnitzer, Electronic health record, White, FCW, Stanford Law School, MITRE, Language, Nursing, Medical imaging, MD

FCW named Jay Schnitzer , MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100 for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs).

Key Points: 
  • FCW named Jay Schnitzer , MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100 for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs).
  • Schnitzer guides MITRE’s $100M independent research and development portfolio , including the company’s initiative to use patient data to help cure cancer.
  • FCW will honor the Federal 100 award winners at a ceremony in Washington, D.C., on April 20.
  • For 34 years, the awards have celebrated government, industry, and academic leaders who are transforming government and its ability to deliver on critical missions.

Opala Launches New Attribution API to Streamline Value-Based Contracting for MultiCare Connected Care

Retrieved on: 
Thursday, November 10, 2022
Hospital, HL7, Da Vinci Project, EHR, Partnership, Health Level Seven International, MultiCare Health System, VBC, Organization, Adoption, Accountable care organization, Efficiency, API, Record, MCC, ACO, Solution, Pharmacy, Contract, Acos, Population health, Vinci SA, CIN, Health Level 7, Patient, FHIR, Multi, ATR, CMS, Insurance, Health insurance, Healthcare, Risk management, Microsoft Excel

SEATTLE, Nov. 10, 2022 /PRNewswire/ -- Opala, a healthcare data exchange solutions provider, today announced commercial availability of its Attribution API, which streamlines delivery of value-based care to patients in a way that yields significant administrative efficiency and improves reimbursement for providers. In tandem, the company announced the first deployment of this solution at MultiCare Connected Care.

Key Points: 
  • In tandem, the company announced the first deployment of this solution at MultiCare Connected Care.
  • Opala piloted the Attribution API with a multi-state health insurance provider in Washington State and Alaska, and MultiCare Connected Care.
  • "Multi-payer data exchange solutions, like Opala's, are key to delivering high-value care," said Anna Taylor, associate vice president of Population Health and Value-based Care at MultiCare.
  • MultiCare Connected Care (MCC) is an independent Accountable Care Organization (ACO) established in 2014 as a wholly owned subsidiary of MultiCare Health System and operates as an independent entity.

The Sequoia Project Seeks Feedback on Draft TEFCA Facilitated FHIR Implementation Guide

Retrieved on: 
Friday, October 7, 2022
Health Level Seven International, ONC, Feedback, Aircraft, Review, Common, Policy, Interoperability, Twitter, Participation, Health Level 7, RCE, Office of the National Coordinator for Health Information Technology, CEO, Nationally Recognized Testing Laboratory, FHIR, GLOBE, Medical device, Risk management

VIENNA, Va., Oct. 07, 2022 (GLOBE NEWSWIRE) -- The Sequoia Project, selected by the Office of the National Coordinator for Health IT (ONC) as the Recognized Coordinating Entity (RCE) to support the implementation of the Trusted Exchange Framework and Common Agreement (TEFCA), released the Draft TEFCA Facilitated FHIR Implementation Guide for stakeholder feedback.

Key Points: 
  • VIENNA, Va., Oct. 07, 2022 (GLOBE NEWSWIRE) -- The Sequoia Project, selected by the Office of the National Coordinator for Health IT (ONC) as the Recognized Coordinating Entity (RCE) to support the implementation of the Trusted Exchange Framework and Common Agreement (TEFCA), released the Draft TEFCA Facilitated FHIR Implementation Guide for stakeholder feedback.
  • Publishing this draft implementation guide for feedback is a critical step as we prepare to launch FHIR pilots later this year.
  • All stakeholder feedback will be thoughtfully considered as the RCE develops and publishes the final TEFCA Facilitated FHIR Implementation Guide Version 1.
  • The Sequoia Project is a non-profit, 501c3, public-private collaborative chartered to advance implementation of secure, interoperable nationwide health information exchange.

Smile CDR Receives U.S. Health Interoperability Standards Certification for Patient Clinical Data

Retrieved on: 
Wednesday, August 24, 2022
Center for Medicare and Medicaid Innovation, Software, Partnership, Patient, HL7, Technology, Centers for Medicare & Medicaid Services, Touchstone, CDR, ACB, Solution, Directory, Global health, United States Department of Health and Human Services, Health Level 7, CMS, Health, API, Self-signed certificate, LinkedIn, Department, ATL, Organization, Office of the National Coordinator for Health Information Technology, Center, FHIR, GLOBE, Risk management, Leadership, Medicare, Compliance, Certification, Twitter, Ensuring Patient Access and Effective Drug Enforcement Act, Health Level Seven International, Provider, Efficiency, Health insurance, Medical device, Medicaid

TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Smile CDR Inc., a leading health data and integration company, received its third certification showing compliance with the Centers for Medicare and Medicaid (CMS) Interoperability and Patient Access Final Rule (CMS-9115-F).

Key Points: 
  • TORONTO, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Smile CDR Inc., a leading health data and integration company, received its third certification showing compliance with the Centers for Medicare and Medicaid (CMS) Interoperability and Patient Access Final Rule (CMS-9115-F).
  • "The Patient Clinical Data Certification establishes that Smile CDR compliantly meets the rigorous CMS requirements and further demonstrates our commitment to liberating health information and advancing interoperability standards, to improve healthcare quality and efficiency."
  • The Drummond certification is the only independent testing and certification program certifying interoperability and compliance with CMS Final Rule standards.
  • Smile CDR Inc. is a health information technology company focused on delivering better global health through open standards.

HL7® Da Vinci Project Names Eight Health IT Professionals '2021 Community Champions'

Retrieved on: 
Tuesday, August 16, 2022
MultiCare Health System, Population health, Health Level Seven International, Accountable care organization, VBC, Industry, Da Vinci Project, ANSI, Committee, Growth, Cambia Health Solutions, Health, FHIR, Hearst Communications, MCG, Leonardo da Vinci, CDA, Acos, Da Vinci, ANN, HL7, Associate, Private sector, Community, Technology, Interoperability, Goal, Vinci SA, MIT EAD Airframe Version 2, Adoption, Management

ANN ARBOR, Mich., Aug.16, 2022 The Health Level Seven International (HL7) Da Vinci Project recently named eight healthcare technology experts as its 2021 Da Vinci Community Champions.

Key Points: 
  • ANN ARBOR, Mich., Aug.16, 2022 The Health Level Seven International (HL7) Da Vinci Project recently named eight healthcare technology experts as its 2021 Da Vinci Community Champions.
  • The awards were announced on July 20, 2022, at the monthly HL7 Da Vinci Project member meeting.
  • "On behalf of the HL7 Da Vinci Project, our Steering Committee, and members, we are delighted to recognize our 2021 Da Vinci Community Champions.
  • To learn more about the HL7 Da Vinci Project and to sign up for the listserv, please visit: hl7.me/davincinews .